All lobbying filings
IONIS PHARMACEUTICALS, INC.
IONIS PHARMACEUTICALS, INC. filed a Q3 report for IONIS PHARMACEUTICALS, INC. on October 15, 2025.
Lobbying for IONIS PHARMACEUTICALS, INC. · Biotechnology company.
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 15, 2025
Expenses
$140,000
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
California
Government bodies contacted
2
Lobbying activity
3
Issues related to the implementation of the Inflation Reduction Act. H.R.1672 - Maintaining Investments in New Innovation Act. H.R.1262/S.932 - Give Kids a Chance Act of 2025. H.R.946/S.1862 - ORPHAN Cures Act. H.R.1492/S.832 - EPIC Act.
Issues related to the implementation of the Inflation Reduction Act. H.R.1672 - Maintaining Investments in New Innovation Act. H.R.946/S.1862 - ORPHAN Cures Act. H.R.1492/S.832 - EPIC Act. Issues related to the Medicaid rebate.
Issues related to the implementation of the Tax Cuts and Jobs Act of 2017. H.R.1414 - Camerons Law.